Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00547833 · ClinicalTrials.gov registry record

Partial Word Knowledge Growth in Children With LLD

A clinical trial of Language Disorders, sponsored by University of Missouri-Columbia.

Completed
Registry status
81
Enrollment target
1
Study location

NCT00547833: Completed study of Language Disorders, sponsored by University of Missouri-Columbia.

NCT00547833 is a study of Language Disorders that has completed, run by University of Missouri-Columbia. The registered enrollment target is 81 participants, roughly in line with the 75-participant average among 7 other Language Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00547833, a study of Language Disorders, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
81 participants
Enrollment target
1
Study location

Study Summary

Children with language-learning disabilities (LLD) have language and reading skills that are weaker than those of typically developing children. In the school-age years, reading is a primary means of exposure to new vocabulary for typically developing children. Although these children would not be expected to master a new word through a single exposure to it in text, children show evidence of partial word knowledge growth (e.g., Wagovich \& Newhoff, 2004). The purpose of this project is to characterize the partial word knowledge growth of children with LLD, in comparison to children with typical language skills. Five forms of partial word knowledge (e.g., orthographic, word discrimination, syntactic, emotional content, and general semantic domain knowledge) are being measured. The study's hypotheses are that children with LLD, like typically developing peers, will demonstrate partial word knowledge growth from exposure to unfamiliar words in text, but that they will show a different pattern of growth across the five forms of partial word knowledge being assessed.

Conditions Studied

Study Locations (1)

Missouri

  • Univ. of Missouri Dept. of Communication Science & Disorders - Columbia

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2006-05
Est. Completion 2009-12
University of Missouri-Columbia

291 total trials

What the finished NCT00547833 record still lists

NCT00547833 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target, roughly in line with the 75-participant average among 7 other Language Disorders trials with a reported enrollment target.

The record links to 1 condition, with Language Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00547833 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT00547833 about?

NCT00547833 is a clinical study titled "Partial Word Knowledge Growth in Children With LLD". Children with language-learning disabilities (LLD) have language and reading skills that are weaker than those of typically developing children. In the school-age years, reading is a primary means of exposure to new vocabulary for typically developing children. Although these children would not be e...

What is the current status of trial NCT00547833?

This trial is currently completed. The enrollment target is 81 participants. The study started on 2006-05. Estimated completion is 2009-12.

What conditions does trial NCT00547833 study?

This clinical trial studies the following conditions: Language Disorders.

Who is sponsoring clinical trial NCT00547833?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00547833 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Language Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04966481 · 81 participants · Phase 3

    Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor

  • NCT05109429 · 81 participants · NA

    Developing a Clinical Outcome Assessment for Opioid Craving

  • NCT05112601 · 81 participants · Phase 2

    Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • NCT05305911 · 81 participants · Phase 2

    Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00547833, the US trial registry maintained by the National Library of Medicine. NCT00547833 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.